The July Immunization Initiatives Newsletter includes the new HPV education and practice-improvement module on the community of immunizers. The community of immunizers site includes educational materials, practice-change resources, discussions boards, provides you with a connection to colleagues who are passionate about immunization. Other topics include vaccine hesitancy and vaccine storage and handling…
Updates and Alerts in Newsletter:
Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) Announces Food and Drug Administration (FDA) approval of Hiberix as a 3-dose primary Hib vaccination series: On January 14, the FDA approved the expanded use of GlaxoSmithKline Biologicals’ (Research Triangle Park, North Carolina) Hiberix (Haemophilus b Conjugate Vaccine [Tetanus Toxoid Conjugate]) for a 3-dose infant primary vaccination series at ages 2, 4, and 6 months. Hiberix had previously been licensed in the United States since August 2009 for use as a booster dose in children aged 15 months through 4 years. That licensure was obtained under the Accelerated Approval Regulations in response to a Haemophilus influenzae type b (Hib) vaccine shortage that lasted from December 2007 to July 2009. This new approval provides an additional vaccine option to other currently-licensed Hib vaccines recommended for the primary vaccination series. On April 29, the CDC reported this change in their MMWR.
AAP Supports ACIP Recommendation for Use of Inactivated Flu Vaccine: On June 22, The CDC ACIP voted that, for the upcoming 2016-’17 influenza season, live attenuated influenza vaccine should not be used in the upcoming 2016-2017 season. The American Academy of Pediatrics (AAP) agrees with the interim recommendation. In light of this recent recommendation, the AAP offers information to help members make the transition for the upcoming 2016-’17 influenza season (Log in required).
CDC Confirms 19 Cases of Measles in Nine States Through May 21: From January 2 through May 21, 19 cases of measles have been confirmed in nine states (Arizona, California, Georgia, Hawaii, Illinois, Massachusetts, Minnesota, Tennessee, and Texas) according to CDC outbreak reporting. Since 2010, 2014 has had the most cases of measles, 667 (in 23 outbreaks) reported in the United States. Last year, 189 cases were reported. Data is updated monthly.
CDC Study Shows Low Risk of Febrile Seizure in Children after Vaccine Receipt: Researchers at the CDC studied children, ages 6 to 23 months, and found that children who received influenza or DTaP vaccine did not have a greater risk of fever- related seizures on the day of or the day following the vaccine, compared to their risk of febrile seizure 14-21 days after vaccine (the control period). Children had only a slightly higher likelihood of febrile seizure following receipt of pneumococcal conjugate vaccine than during the control period. The study was published in Pediatrics, and also showed that only up to 30 per 100,000 children given all three vaccines at once were likely to have febrile seizures.
Find out more about these Upcoming Events:
- National Immunization Awareness Month
- CDC 47th National Immunization Conference- September 13–15, 2016
- Advisory Committee on Immunization Practices- October 19-20, 2016
- AAP Immunization Web pages
- AAP Community of Immunizers
Special Section on HPV and MUCH MORE!